The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations

Trends in Cardiovascular Medicine

Volumn 8, Issue 5, 1998, Pages 191-199

  Kol, Amir ^a   Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; HERPES SIMPLEX VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROEPIDEMIOLOGY; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

EID: 0031817377     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00010-3     Document Type: Article

References (110)

1. Adam E, Melnick JL, Probesfield JL, et al.: 1987. High levels of cytomegalovirus anti-body in patients requiring vascular surgery for atherosclerosis. Lancet 2:291-293.
2. Almeida GD, Porada CD, St Jeor S, Ascensao JL: 1994. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 83:370-376.
3. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al.: 1988. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12:56-62.
4. Beatty WL, Byrne GI, Morrison RP: 1993. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 90:3998-4002.
5. Beatty WL, Morrison RP, Byrne GI: 1994. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 58:686-699.
6. Benditt EP, Benditt JM: 1973. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 70:1753-1756.
7. Benditt EP, Barett T, MacDougal JK: 1983. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 80:6386-6389.
8. Biasucci LM, Vitelli A, Liuzzo G, et al.: 1996. Elevated levels of interleukin-6 in unstable angina. Circulation 94:874-877.
9. Blasi F, Denti F, Erba M, et al.: 1996. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 34:2766-2769.
10. Bok RA, Jacob HS, Balla J, et al.: 1993. Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor. Thromb Haemost 69:253-258.
11. Bruggeman CA, van Dam-Mieras MCE: 1991. The possible role of cytomegalovirus in atherogenesis. In Melnick JL, ed. Progress in Medical Virology, vol 38. Basel, Karger, pp 1-26.
12. Bruschke AV, Kramer JR Jr, Bal ET, et al.: 1989. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J 117:296-305.
13. Cameron IR, Park M, Dutia BM, Ore A, Macnab JCM: 1985. Herpes simplex virus sequences involved in the initiation of oncogenic morphological transformation of rat cells are not required for maintenance of the transformed state. J Gen Virol 66:517-527.
14. Campbell LA, O'Brien ER, Cappuccio AL, et al.: 1995. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 172:585-588.
15. Castell JV, Gomez-Lechon MJ, David M, et al.: 1990. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12:1179-1186.
16. Cines DB, Lyss AP, Bina M, et al.: 1982. Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells. J Clin Invest 69:123-128.
17. Cook PJ, Honeybourne D: 1994. Chlamydia pneumoniae. J Antimicrob Chemother 34: 859-873.
18. Danesh J, Collins R, Peto R: 1997. Chronic infections and coronary heart disease: is there a link? Lancet 350:430-436.
19. Datta SK, Tumilowicz JJ, Trentin JJ: 1993. Lysis of human arterial smooth muscle cells infected with herpesviridae by peripheral blood mononuclear cells: implications for atherosclerosis. Viral Immunol 6:153-160.
20. Davies MJ: 1996. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94:2013-2020.
21. Davies MJ, Thomas AC: 1985. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J 53:363-373.
22. Dinarello CA, Ikejima T, Warner SJC, et al.: 1987. Interleukin-1 induces interleukin-1. I. Induction of circulating interleukin-1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 139:1902-1910.
23. Doolittle RF, Hunkapiller MW, Hood LE, et al.: 1983. Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221:275-277.
24. Dudding L, Haskel S, Clark BD, et al.: 1989. Cytomegalovirus infection stimulates expression of monocyte associated mediator genes. J Immunol 143:3343-3352.
25. El-Beik T, Razzaque A, Jariwalla RJ, Cihlar RL, Rosenthal LJ: 1986. Multiple transforming regions of human cytomegalovirus DNA. J Virol 60:645-652.
26. Etingin OR, Hajjar DP: 1990. Evidence for cytokine regulation of cholesterol metabolism in herpesvirus-infected arterial cells by the lypoxygenase pathways. J Lipid Res 31:299-305.
27. Etingin OR, Silverstein RL, Hajjar DP: 1991. Identification of a monocyte receptor on herpesvirus-infected endothelial cells. Proc Natl Acad Sci USA 88:7200-7203.
28. Everett JP, Hershberger RE, Norman DJ, et al.: 1992. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 11:S133-137.
29. Fabricant CG, Fabricant J, Litrenta MM, Minick CR: 1978. Virus induced atherosclerosis. J Exp Med 148:335-340.
30. Fenwick ML, Clark J: 1982. Early and delayed shut off of host protein synthesis in cells infected with herpes simplex virus. J Gen Virol 61:121-125.
31. Fleet JC, Clinton SK, Salomon RN, Loppnow H, Libby P: 1992. Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae. J Nutr 122:294-305.
32. Fong IW, Chiu B, Viira E, et al.: 1997. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 35:48-52.
33. Friedman HM, Macarack EJ, MacGregor RR, Wolfe J, Kefalides NA: 1981. Virus infection of endothelial cells. J Infect Dis 144:266-273.
34. Friedman HM, Cohen GH, Eisenberg RJ, Sidel CA, Cines DB: 1984. Glycoprotein C of herpes simplex virus I acts as a receptor for the C3b complement component on infected cells. Nature 309:633-635.
35. Fryert RH, Schwobe EP, Woods ML, Rodgers GM: 1997. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med 45:168-174.
36. Galloway DA, McDougall JK: 1983. The oncogenic potential of herpes simplex viruses: evidence for a "hit and run" mechanism. Nature 302:21-24.
37. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC: 1996. Replication of Chlamydia pneumoniiae in vitro in human macrophages, endothelial cells and aortic artery smooth muscle cells. Infect Immun 64:1614-1620.
38. Giroud D, Li JM, Urban P, Meier B, Rutishauer W: 1992. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 69:729-732.
39. Godzin K, O'Brien ER, Wang SK, Kuo CC: 1995. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 33:2411-2414.
40. Gosselin J, Flamand L, D'Addario M, Hiscott J, Menezes J: 1992. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses: differential induction of interleukin 6 and tumor necrosis factor-alpha. J Clin Invest 89:1849-1856.
41. Grattan MT, Moreno-Cabral CE, Starnes VA, et al.: 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566.
42. Gupta S, Leatham EW, Carrington D, et al.: 1997. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azytromicin in male survivors of myocardial infarction. Circulation 96:404-407.
43. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B: 1997. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 350:404-407.
44. Gyorkey F, Melnick JL, Guinn GA, Gyorkey P, Debakey ME: 1984. Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta in arteriosclerotic patients. Exp Mol Pathol 40:328-339.
45. Hackett D, Davies G, Maseri A: 1988. Preexisting coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J 9:1317-1323.
46. Hajjar DP, Fabricant CG, Minick CR, Fabricant J: 1986. Virus induced atherosclerosis: herpes virus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol 122:62-70.
47. Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, Grant AJ: 1987. Herpes simplex virus infection in human arterial cells. J Clin Invest 80:1317-1321.
48. Hajjar DP, Nicholson AC, Hajjar KA, Sando GN, Summers BD: 1989. Decreased messenger RNA translation in herpesvirus-infected arterial cells: effects on cholesteryl ester hydrolase. Proc Natl Acad Sci USA 86:3366-3370.
49. Healy AM, Gelehrter TD: 1994. Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the acute phase response. J Biol Chem 269: 19,095-19,100.
50. Hendrix MGR, Dormans PHJ, Kitslaar P, Bosman F, Bruggeman C: 1989. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and non-atherosclerotic patients. Am J Pathol 134: 1151-1157.
51. Hendrix MGR, Salimans MMM, van Boven CPA, Bruggeman CA: 1990. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 136:23-28.
52. Hendrix MGR, Daemen M, Bruggeman CA: 1991. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 138:563-567.
53. Ho DD, Rota TR, Andrews CA, Hirsch MS: 1984. Replication of human cytomegalovirus in endothelial cells. J Infect Dis 150: 956-957.
54. Hwang CBC, Shillitoe EJ: 1990. DNA sequence of mutations induced in cells by herpes simplex virus type-1. Virology 178: 180-188.
55. Jackson LA, Campbell LA, Kuo CC, et al.: 1997a. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 176:292-295.
56. Jackson LA, Campbell LA, Schmidt RA, et al.: 1997b. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol 150:1785-1790.
57. Kaukoranta-Tolvanen SS, Laitinen K, Saikku P, Leinonen M: 1994. Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog 16:313-319.
58. Kaukoranta-Tolvanen SS, Ronni T, Leinonen M, Saikku P, Laitinen K: 1996a. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog 21:407-411.
59. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, et al.: 1996b. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 21:215-221.
60. Kefalides NA, Ziaie S: 1986. Herpes simplex virus suppression of human endothelial matrix protein synthesis is independent of viral protein synthesis. Lab Invest 55:328-336.
61. Key NS, Vercellotti GM, Winkelmann JC, et al.: 1990. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci USA 87:7095-7099.
62. Key NS, Bach RR, Vercellotti GM, Moldow CF: 1993. Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells. Lab Invest 68:645-651.
63. Kol A, Sperti G, Shani J, et al.: 1995. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 91: 1910-1913.
64. Kuo CC, Shor A, Campbell LA, et al.: 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167:841-849.
65. Kuo CC, Grayston JT, Campbell LA, et al.: 1995. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 92: 6911-6914.
66. Lashgari MS, Friedman HM, Kefalides NA: 1987. Suppression of matrix protein synthesis by herpes simplex virus in bovine smooth muscle cells. Biochem Biophys Res Commun 143:145-151.
67. Laurila A, Bloigu A, Nayha S, et al.: 1997. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 17: 2910-2913.
68. Libby P: 1995. Molecular bases of the acute coronary syndromes. Circulation 91:2844-2850.
69. Libby P, Ordovas JM, Auger KR, et al.: 1986. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol 124:179-186.
70. Libby P, Loppnow H, Girard J: 1989. The roles of endothelial cells in septic shock. In Chocs Septiques en Pédiatrie. Beaufils F, Mercier JC, eds. Paris, Arnette, pp 25-31.
71. Libby P, Fleet JC, Salomon RN, et al.: 1992. Possible role of cytokines in atherogenesis. In Stein O, Eisenberg S, Stein Y, eds. Atherosclerosis IX: Proceedings of the Ninth International Symposium on Atherosclerosis. Tel Aviv, R & L Creative Communications Ltd., pp 339-350.
72. Libby P, Egan D, Skarlatos S: 1997. Role of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 96:4095-4103.
73. Linnanmaki E, Leinonen M, Elkman MR, et al.: 1993. Chlamydiae specific circulating immune-complexes in chronic coronary artery disease. Circulation 87:1130-1134.
74. Little WC, Costantinescu M, Applegate RJ, et al.: 1988. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78: 1157-1166.
75. Liuzzo G, Biasucci LM, Gallimore JR, et al.: 1994. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331:417-424.
76. MacDonald K, Rector TS, Braunlin EA, Coubo SH, Olivare MT: 1989. Association of coronary artery disease and cardiac transplant recipients with cytomegalovirus infection. Am J Pathol 64:359-362.
77. McEver RP: 1991. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 45:156-161.
78. Melnick JL, Adam E, Debakey ME: 1993. Cytomegalovirus and atherosclerosis. Eur Heart J 14(Suppl K):30-38.
79. Minick CR, Murphy GE: 1973. Experimental induction of arteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. II. Effect of repeatedly injected foreign protein in rabbits fed a lipid-rich, cholesterol-poor diet. Am J Pathol 73:265-300.
80. Moazed TC, Kuo C, Grayston JT, Campbell LA: 1997. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 175:883-890.
81. Muhlestein JB, Hammond EH, Carlquist JF, et al.: 1996. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerosis versus other forms of cardiovascular disease. J Am Coll Cardiol 27:1555-1561.
82. Nachtigal M, Legrand A, Nagpal ML, Nachtigal SA, Greenspan SA: 1990. Transformation of rabbit vascular smooth muscle cells by transfection with the early region of SV40 DNA. Am J Pathol 136:297-306.
83. Nahmias A, Josey K: 1978. Epidemiology of Herpes simplex virus 1 and 2. In Evans AS, ed. Viral Infections of Humans - Epidemiology and Control. New York, Plenum Medical Book Co, pp 253-271.
84. Nishioka Y, Silverstein S: 1977. Degradation of cellular mRNA during infection by herpes simplex virus. Proc Natl Acad Sci USA 74:2370-2374.
85. Nobuyoshi M, Tanaka M, Nosaka H, et al.: 1991. Progression of coronary atherosclerosis: is coronary spasm related to progression? J Am Coll Cardiol 18:904-910.
86. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D: 1996. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 49: 102-106.
87. Ossei-Gerning N, Moayyedi P, Smith S, et al.: 1997. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 35: 120-124.
88. Penn A, Garte SJ, Warren L, Nesta D, Mindich B: 1986. Transforming gene in human atherosclerotic plaque DNA. Proc Natl Acad Sci USA 83:7591-7595.
89. Ramirez JA: 1996. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 125:979-982.
90. Saikku P: 1993. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 14(Suppl K):62-65.
91. Saikku P, Leinonen M, Mattila K, et al.: 1988. Serologic evidence of an association of a novel Chlamydia, TWAR, with coronary artery disease and acute myocardial infarction. Lancet 2:983-986.
92. Schett G, Xu Q, Amberger A, et al.: 1995. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 96:2569-2577.
93. Sorlie PD, Adam E, Melnick SL, et al.: 1994. Cytomegalovirus/herpesvirus and carotid atherosclerosis. The ARIC study. J Med Virol 42:33-37.
94. Span AHM, van Boven CPA, Bruggeman CA: 1989. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leukocytes to endothelial cells. Eur J Clin Invest 19:542-548.
95. Speir E, Modali R, Huang ES, et al.: 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
96. Thom DH, Wang SP, Grayston JT, et al.: 1991. Chlamydia pneumoniae strain TWAR anti-body and angiographically demonstrated coronary artery disease. Arterioscler Thromb 11:547-551.
97. Tumilowicz JJ, Gawlick ME, Powell BB, Trenton JJ: 1985. Replication of human cytomegalovirus in human arterial smooth muscle cells. J Virol 56:839-845.
98. Van Dorp WT, Jonges E, Bruggeman CA, et al.: 1987. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Thromb Res 47:69-75.
99. Visser M, Vercellotti GM: 1993. Herpes simplex virus and atherosclerosis. Eur Heart J 14(Suppl K):39-42.
100. Visser M, Tracy PB, Vercellotti GM, et al.: 1988. Enhanced thrombin generation and platelet binding on herpes simplex virus infected endothelium. Proc Natl Acad Sci USA 85:8227-8230.
101. Waldman WJ, Adams PW, Orosz CG, Sedmak DD: 1992. T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation 54:887-896.
102. Warner SJC, Auger KR, Libby P: 1987a. Human interleukin-1 induces interleukin-1 gene expression in human vascular smooth muscle cells. J Exp Med 165:1316-1331.
103. Warner SJC, Auger KR, Libby P: 1987b. Interleukin-1 induces interleukin-1. II. Recombinant human interleukin-1 induces interleukin-1 production by adult human vascular endothelial cells. J Immunol 139: 1911-1917.
104. Weiss SM, Roblin PM, Gaydos CA, et al.: 1996. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173: 957-962.
105. Xu Q, Dietrich H, Steiner HG, et al.: 1992. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 12:789-799.
106. Xu Q, Willeit J, Marosi M, et al.: 1993. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341:255-259.
107. Xu Q, Schett G, Seitz CS, et al.: 1994. Surface staining and cytotoxic activity of heat shock protein 60 antibody on stressed aortic endothelial cells. Circ Res 75:1078-1085.
108. Yamashiroya HM, Ghosh L, Yang R, Robertson AL Jr: 1988. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 130:71-79.
109. Young RA, Elliot TJ: 1989. Stress proteins, infection and immune surveillance. Cell 59:5-8.
110. Zhou YF, Leon MB, Waclawiw MA, et al.: 1996. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 335:624-630.